<DOC>
	<DOCNO>NCT01936675</DOCNO>
	<brief_summary>This study do well understand genetic information might improve assessment heart attack risk .</brief_summary>
	<brief_title>Myocardial Infarction Genes ( MI-GENES ) Study</brief_title>
	<detailed_description>This study aim randomize patient 2 arm . The first arm receive conventional Framingham risk score coronary heart disease intervention arm receive genetics-informed risk coronary artery disease . The investigator assess baseline blood lipid level follow 2 arm 6 month randomization . Primary endpoint change LDL level 2 arm . Secondary outcome include blood pressure control , weight , smoke cessation , lifestyle modification . This trial help u understand whether coronary artery disease risk derive genetic information would significant impact patient ' perception coronary artery disease risk motivate healthy lifestyle modification reduce long term risk .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<criteria>Patients age 4570 year Patients participate Mayo Clinic Biobank previous research study Mayo Clinic Patients live Southeast Minnesota Taking statin lipid lower medication Patients history myocardial infarction , coronary artery disease , atherosclerotic medical condition</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Coronary Artery Disease</keyword>
	<keyword>Myocardial Infarction</keyword>
	<keyword>Genomic Risk Communication</keyword>
	<keyword>Risk Stratification</keyword>
</DOC>